Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2019 May-Jun;32(3):247-256.
doi: 10.20524/aog.2019.0351. Epub 2019 Jan 15.

Improving immunization strategies in patients with inflammatory bowel disease

Affiliations
Review

Improving immunization strategies in patients with inflammatory bowel disease

Maham Farshidpour et al. Ann Gastroenterol. 2019 May-Jun.

Abstract

Patients with inflammatory bowel disease (IBD) are susceptible to varieties of opportunistic infections due to immunological changes in the setting of their disease and drug-induced immunosuppression. Even though numerous infections can be prevented by vaccine, vaccination in IBD patients is inadequate. Data showed only 9% were vaccinated against pneumococcal infection and 28% described commonly receiving influenza vaccine. This review article discusses the recent immunizations against influenza virus; pneumococcal infection; human papilloma virus; tetanus, diphtheria and pertussis; measles, mumps and rubella; varicella zoster; and herpes zoster for individuals diagnosed with IBD and those patients with drug-related immunosuppression. In addition, this review discusses concerns about IBD patients planning to travel abroad. Immunization status and screening for opportunistic infection need to be addressed in IBD patients at the time of diagnosis and they should be vaccinated accordingly. Generally, standard vaccination strategies should be pursued in IBD patients, although live vaccines should be avoided while they are not immunocompetent.

Keywords: Inflammatory bowel disease; immunization; opportunistic infections.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest: None

References

    1. Rubin DC, Shaker A, Levin MS. Chronic intestinal inflammation:inflammatory bowel disease and colitis-associated colon cancer. Front Immunol. 2012;3:107. - PMC - PubMed
    1. Bernheim O, Colombel JF, Ullman TA, Laharie D, Beaugerie L, Itzkowitz SH. The management of immunosuppression in patients with inflammatory bowel disease and cancer. Gut. 2013;62:1523–1528. - PubMed
    1. Chaudrey K, Salvaggio M, Ahmed A, Mahmood S, Ali T. Updates in vaccination:recommendations for adult inflammatory bowel disease patients. World J Gastroenterol. 2015;21:3184–3196. - PMC - PubMed
    1. Sands BE, Cuffari C, Katz J, et al. Guidelines for immunizations in patients with inflammatory bowel disease. Inflamm Bowel Dis. 2004;10:677–692. - PubMed
    1. Nguyen DL, Nguyen ET, Bechtold ML. Effect of immunosuppressive therapies for the treatment of inflammatory bowel disease on response to routine vaccinations:a meta-analysis. Dig Dis Sci. 2015;60:2446–2453. - PubMed

LinkOut - more resources